By Will Boggs MD (Reuters Health) – Higher education may build a stronger foundation for overall brain function, but starting from this higher level of function doesn’t influence how fast cognition declines in old...
Read MoreBy Ceyda Caglayan and Ezgi Erkoyun ISTANBUL (Reuters) – The shelf of heart disease drugs in Hulya Akpinar’s Istanbul pharmacy is almost bare, and patients seeking medicine for blood pressure and diabetes leave...
Read More
By Nate Raymond (Reuters) – The U.S. Justice Department on Wednesday said it had filed a...
Read MoreBy Tamara Mathias (Reuters Health) – Certain tumors labeled as “cancer” aren’t life-threatening and should be called something else instead, some doctors believe. When patients receive a cancer diagnosis,...
Read More
By Lawrence Hurley WASHINGTON (Reuters) – President Donald Trump urged lawmakers in his...
Read MoreBy Lisa Rapaport (Reuters Health) – Many patient advocacy groups focused on skin conditions receive funding from companies that sell dermatology treatments, and a new study suggests these nonprofits don’t always...
Read More(Reuters) – The U.S. Food and Drug Administration (FDA) said on Wednesday it had approved Sanofi SA’s drug to treat a rare blood-clotting disorder in adults in combination with standard-of-care treatments. The...
Read More
By Allison Martell and Anna Mehler Paperny TORONTO (Reuters) – Canadian pharmaceutical...
Read More
By Tamara Mathias (Reuters) – Eli Lilly and Co on Wednesday embraced a U.S. government...
Read More
By Catherine Lagrange LYON, France (Reuters) – A decade-old lawsuit in which a French farmer...
Read More
TOKYO (Reuters) – Japan’s swine fever outbreak has spread to five prefectures...
Read More
ZURICH (Reuters) – Switzerland’s Roche will donate its new hemophilia A drug Hemlibra...
Read More
However, lean mass and absolute grip strength decline after surgery
Read More
No difference in patient, graft survival; increased costs seen for A2 to B deceased donor kidney transplant
Read More
222 percent increase in HCV infection rates seen after reformulation in states with above-median misuse
Read More
Overprescribing tied to newer antidepressants, non-face-to-face interactions with prescribers
Read More
Noncalcified plaque burden and necrotic core reduced in association with biologic therapy
Read More
No difference seen in proportion reaching primary end point versus conventional strategy
Read More
Prevalence of hypertensive crisis is 11.4 percent in this population
Read More
Decline seen in postoperative opioid requirements after elective spinal, peripheral nerve surgery
Read More
